Improved Patent Law in The Pharmaceutical Industry

There is movement in the Chinese pharmaceutical IP: On 17 October 2020, the Standing Committee of the National People’s Congress formally adopted the fourth amendment to the Chinese Patent Law. The new law will enter into force on 1 June 2021 and will be of great importance for pharmaceutical companies in China, as it contains… Continue reading Improved Patent Law in The Pharmaceutical Industry

Extension of the Patent Term: A Driver for Innovation

The trade agreement between the USA and China provides for the extension of the patent term of innovative medical devices to avoid undue delays. This is to the benefit of pharmaceutical companies in both countries. The contractual clause not only supports pharmaceutical manufacturers from the USA, it also benefits innovative Chinese pharmaceutical companies. These companies… Continue reading Extension of the Patent Term: A Driver for Innovation